MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bmc.2022.116807

Медицинская библиотека · Bioorganic & medicinal chemistry · 2022

Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease.

Moutayakine Amina, Marques Carolina, López Óscar, Bagetta Donatella, Leitzbach Luisa, Hagenow Stefanie, Carreiro Elisabete P, Stark Holger, Alcaro Stefano, Fernández-Bolaños José G, Burke Anthony J

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The chromane ring system is widely distributed in nature and has proven to be a highly potent pharmacophore in medicinal chemistry, which includes the area of Alzheimer's and Parkinson's diseases. We report on the development of a gem-dimethylchroman-4-ol family that was shown to give good inhibition of equine serum butyrylcholinesterase (eqBuChE) (in the range 2.9 - 7.3 μM) and in the same range of currently used drugs. We also synthesized a small library of gem-dimethylchroman-4-amine compounds, via a simple reductive amination of the corresponding chromanone precursor, that were also selective for eqBuChE presenting inhibitions in the range 7.6 - 67 μM. Kinetic studies revealed that they were mixed inhibitors. Insights into their mechanism of action were obtained through molecular docking and STD-NMR experiments, and the most active examples showed excellent drug-likeness and pharmacological properties predicted using Swiss-ADME. We also prepared a set of propargyl gem-dimethylchromanamines, for monoamine oxidase (MAO) inhibition but they were only moderately active (the best being 28% inhibition at 1 µM on MAO-B). Overall, our compounds were found to be best suited as inhibitors for BuChE.

Для цитирования: Moutayakine Amina, Marques Carolina, López Óscar, Bagetta Donatella, Leitzbach Luisa, Hagenow Stefanie, Carreiro Elisabete P, Stark Holger, Alcaro Stefano, Fernández-Bolaños José G, Burke Anthony J. Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease.. Bioorganic & medicinal chemistry. 2022. DOI: 10.1016/j.bmc.2022.116807.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.